abstract
- Sommer I, Ledinger D, Thaler K, et al. Outpatient treatment of confirmed COVID-19: a living, rapid evidence review for the American College of Physicians (version 2). Ann Intern Med. 2023;176:1377-1385. 37722115.
In outpatients with COVID-19 during Omicron variant circulation, molnupiravir and nirmatrelvir–ritonavir improved outcomes
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
authors
status
publication date
- January 2024
has subject area
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Antiviral Agents (MeSH)
- COVID-19 (MeSH)
- COVID-19 Drug Treatment (MeSH)
- Cytidine (MeSH)
- Humans (MeSH)
- Hydroxylamines (MeSH)
- Lactams (MeSH)
- Leucine (MeSH)
- Nitriles (MeSH)
- Outpatients (MeSH)
- Proline (MeSH)
- Ritonavir (MeSH)
- SARS-CoV-2 (MeSH)
published in
- ACP journal club Journal